MedAdvisor Limited

ASX:MDR

MedAdvisor Limited

ASX:MDR
TradeAdd trade order Follow Unfollow Set Price Alert
$0.290 (-3.3%)
Last close price
--
Rank
0
Held by
15
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (4) My Report Forum Investors
Top member reports
Consensus
shadow
Company Report
Last edited 3 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#289
Performance (40m)
0.8% pa
Followed by
12
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#ASX Announcements
stale
shadow
Added 3 years ago
View author's company report

MedAdvisor signs 5-year deal with Australian Pharmaceutical Industries (ASX:API) - July 31 2021

Old news now, but noticed there wasn't a straw for this.

Highlights of this deal:

  • 5-year agreement with API, a pharmacy group listed in the ASX known for Priceline Pharmacy stores (among others).
  • Expected revenue is approximately $2.5m over 5 years before transaction and other variable fees (The model is a monthly  recurring  licence  fee).
  • Medadviser will be the framework for the Priceline Covid-19 Vaccination booking (now live) and also a branded version of its mobile application for the Priceline Pharmacy network

That being said I went ahead to book for my vaccination and it was quite satisfying to see it working well as a MDR shareholder, although the UI could use some improvements. It would be great to see more contracts like this come through given the government is extending COVID-19  vaccinations  being  available  in  selected pharmacies.